Psychemedics Accumulated Depreciation from 2010 to 2024

PMD Stock  USD 2.58  0.02  0.78%   
Psychemedics' Accumulated Depreciation is decreasing over the years with slightly volatile fluctuation. Accumulated Depreciation is expected to dwindle to about -15.3 M. During the period from 2010 to 2024 Psychemedics Accumulated Depreciation annual values regression line had coefficient of variation of (38.12) and r-squared of  0.58. View All Fundamentals
 
Accumulated Depreciation  
First Reported
2010-12-31
Previous Quarter
-14.6 M
Current Value
-15.3 M
Quarterly Volatility
4.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Psychemedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psychemedics main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 47 K or Total Revenue of 20.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.73, Dividend Yield of 0.0346 or PTB Ratio of 2.42. Psychemedics financial statements analysis is a perfect complement when working with Psychemedics Valuation or Volatility modules.
  
This module can also supplement various Psychemedics Technical models . Check out the analysis of Psychemedics Correlation against competitors.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.

Latest Psychemedics' Accumulated Depreciation Growth Pattern

Below is the plot of the Accumulated Depreciation of Psychemedics over the last few years. Accumulated depreciation is the total amount of depreciation for Psychemedics fixed asset that has been charged to Psychemedics expense since that asset was acquired and made available for Psychemedics use. The accumulated depreciation account is Psychemedics asset account with a credit balance. It is also known as a contra asset account and appears on the balance sheet as a reduction from the gross amount of fixed assets reported by Psychemedics. It is Psychemedics' Accumulated Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psychemedics' overall financial position and show how it may be relating to other accounts over time.
Accumulated Depreciation10 Years Trend
Slightly volatile
   Accumulated Depreciation   
       Timeline  

Psychemedics Accumulated Depreciation Regression Statistics

Arithmetic Mean(11,509,160)
Coefficient Of Variation(38.12)
Mean Deviation3,681,225
Median(11,670,000)
Standard Deviation4,387,600
Sample Variance19.3T
Range11.8M
R-Value(0.76)
Mean Square Error8.7T
R-Squared0.58
Significance0.001
Slope(746,903)
Total Sum of Squares269.5T

Psychemedics Accumulated Depreciation History

2024-15.3 M
2023-14.6 M
2019-16.2 M
2018-13.3 M
2017-11.7 M
2016-8.9 M
2015-6.6 M

About Psychemedics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Psychemedics income statement, its balance sheet, and the statement of cash flows. Psychemedics investors use historical funamental indicators, such as Psychemedics's Accumulated Depreciation, to determine how well the company is positioned to perform in the future. Although Psychemedics investors may use each financial statement separately, they are all related. The changes in Psychemedics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Psychemedics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Psychemedics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Psychemedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Depreciation-14.6 M-15.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports:
Check out the analysis of Psychemedics Correlation against competitors.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Psychemedics Stock analysis

When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Dividend Share
0.07
Earnings Share
(0.72)
Revenue Per Share
3.85
Quarterly Revenue Growth
(0.12)
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.